Skip to main content
Top

Cellular Oncology

Issue 2/2023

Content (15 Articles)

Open Access Metastasis Review

Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer

Tristan Joseph Verhoeff, Adele F. Holloway, Joanne L. Dickinson

Metastasis Original Article

Targeting tumor-intrinsic PD-L1 suppresses the progression and aggressiveness of head and neck cancer by inhibiting GSK3β-dependent Snail degradation

Chi-Hyun Ahn, Kyu-Young Oh, Bohwan Jin, Won Woo Lee, Jihoon Kim, Hyun-Ji Kim, Dong-Guk Park, Neeti Swarup, Kunal Chawla, Mi Heon Ryu, Uk-Kyu Kim, Su-Jung Choi, Hye-Jung Yoon, Seong-Doo Hong, Ji-Ae Shin, Sung-Dae Cho

Metastasis Original Article

Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation

Hongxia Cheng, Sikai Wang, Dongmei Gao, Kangkang Yu, Huaping Chen, Yilan Huang, Miaomiao Li, Jubo Zhang, Kun Guo

Open Access Original Article

OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening

Christophe Deben, Edgar Cardenas De La Hoz, Maxim Le Compte, Paul Van Schil, Jeroen M.H. Hendriks, Patrick Lauwers, Suresh Krishan Yogeswaran, Filip Lardon, Patrick Pauwels, Steven Van Laere, Annemie Bogaerts, Evelien Smits, Steve Vanlanduit, Abraham Lin

Open Access Metastasis Original Article

Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux

Bo Ni, Xuan He, Yeqian Zhang, Zeyu Wang, Zhongyi Dong, Xiang Xia, Gang Zhao, Hui Cao, Chunchao Zhu, Qing Li, Jiahua Liu, Huimin Chen, Zizhen Zhang

Open Access Original Article

Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth

Karthiga Santhana Kumar, Cyrill Brunner, Matthias Schuster, Levi Luca Kopp, Alexandre Gries, Shen Yan, Simon Jurt, Kerstin Moehle, Dominique Bruns, Michael Grotzer, Oliver Zerbe, Gisbert Schneider, Martin Baumgartner

Open Access Colorectal Cancer Original Article

Protamine 1 as a secreted colorectal cancer-specific antigen facilitating G1/S phase transition under nutrient stress conditions

Shengnan Ren, Dingquan Yang, Yongli Dong, Weidong Ni, Meiqi Wang, Lei Xing, Tong Liu, Wenjia Hou, Weixuan Sun, Haolong Zhang, Zhentao Yu, Yi Liu, Jingrui Cao, Hongbo Yan, Ye Feng, Xuedong Fang, Quan Wang, Fangfang Chen

Breast Cancer Original Article

H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis

Ning Xie, Ruihua Zhang, Zhuofei Bi, Wei Ren, Kaiyun You, Hai Hu, Ying Xu, Herui Yao

Open Access Melanoma Original Article

WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma

Nicholas Coupe, Lina Guo, Esther Bridges, Leticia Campo, Olivia Espinosa, Richard Colling, Andrea Marshall, Ashwin Nandakumar, Ruud van Stiphout, Francesca M. Buffa, Pippa G. Corrie, Mark R. Middleton, Valentine M. Macaulay

Open Access Salivary Gland Cancer Original Article

Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting

Yoshihiro Aizawa, Kentaro Takada, Jun Aoyama, Daisuke Sano, Shoji Yamanaka, Masahide Seki, Yuta Kuze, Jordan A. Ramilowski, Ryo Okuda, Yasuharu Ueno, Yusuke Nojima, Yoshiaki Inayama, Hiromitsu Hatakeyama, Takashi Hatano, Hideaki Takahashi, Goshi Nishimura, Satoshi Fujii, Yutaka Suzuki, Hideki Taniguchi, Nobuhiko Oridate

Gastric Cancer Original Article

TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling

Xin Zhang, Xiusheng Wu, Ying Sun, Yali Chu, Fengjun Liu, Cheng Chen

Metastasis Original Article

Reciprocal FGF19-GLI2 signaling induces epithelial-to-mesenchymal transition to promote lung squamous cell carcinoma metastasis

Yanshuang Zhang, Tingyu Wu, Yuting Wang, Zhuo Chen, Jiachen Chen, Shun Lu, Weiliang Xia

YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m6A-mediated YWHAZ stability

Jihua Chai, Qifan Wang, Qiang Qiu, Guoqiang Han, Yilin Chen, Weiming Li, Haojian Zhang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine